Skip to main navigation Skip to search Skip to main content

American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease

  • American Gastroenterological Association Institute Clinical Guidelines Committee
  • , American Gastroenterological Association Institute Clinical Guidelines Committee
  • , Joseph D. Feuerstein
  • , Geoffrey C. Nguyen
  • , Sonia S. Kupfer
  • , Yngve Falck-Ytter
  • , Siddharth Singh
  • , Lauren Gerson
  • , Ikuo Hirano
  • , Joel H. Rubenstein
  • , Walter E. Smalley
  • , Neil Stollman
  • , Shahnaz Sultan
  • , Santhi S. Vege
  • , Sachin B. Wani
  • , David Weinberg
  • , Yu Xiao Yang
  • Beth Israel Deaconess Medical Center
  • University of Toronto
  • University of Chicago
  • U.S. Department of Veterans Affairs
  • University of California at San Diego

Research output: Contribution to journalArticlepeer-review

554 Scopus citations
Original languageEnglish
Pages (from-to)827-834
Number of pages8
JournalGastroenterology
Volume153
Issue number3
DOIs
StatePublished - Sep 1 2017

Keywords

  • 6-TGN
  • 6-thioguanine
  • AGA
  • American Gastroenterological Association
  • CBC
  • CI
  • GRADE
  • Grading of Recommendations Assessment, Development and Evaluation
  • IBD
  • RCT
  • RR
  • TDM
  • TNF
  • TPMT
  • complete blood count
  • confidence interval
  • inflammatory bowel disease
  • randomized controlled trial
  • relative risk
  • therapeutic drug monitoring
  • thiopurine methyltransferase
  • tumor necrosis factor

Fingerprint

Dive into the research topics of 'American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease'. Together they form a unique fingerprint.

Cite this